BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1577391)

  • 1. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
    Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
    Pace F; Sangaletti O; Zhu H; Bianchi Porro G
    Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
    Pace F; Sangaletti O; Bianchi Porro G
    Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R
    Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastroesophageal reflux disease in preschool children with asthma].
    Yoshida Y; Kameda M; Nishikido T; Takamatu I; Doi S
    Arerugi; 2008 May; 57(5):529-35. PubMed ID: 18520174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial.
    Konturek JW; Beneke M; Koppermann R; Petersen-Braun M; Weingärtner U
    Med Sci Monit; 2007 Jan; 13(1):CR44-9. PubMed ID: 17179910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.